Pancreatic resection for intraductal papillary mucinous neoplasm– a thirteen-year single center experience
Open Access
- 4 November 2016
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 16 (1) , 1-14
Abstract
The purpose of this study is to review our results for pancreatic resection in patients with intraductal papillary mucinous neoplasm (IPMN) with and without associated carcinoma. A total of 54 patients undergoing pancreatic resection for IPMN in a single university surgical center (Medical University of Graz) were reviewed retrospectively. Their survival rates were compared to those of patients with pancreatic ductal adenocarcinoma. Twenty-four patients exhibit non-invasive IPMN and thirty patients invasive IPMN with associated carcinoma. The mean age is 67 (+/-11) years, 43 % female. Surgical strategies include classical or pylorus-preserving Whipple procedure (n = 30), distal (n = 13) or total pancreatectomy (n = 11), and additional portal venous resection in three patients (n = 3). Median intensive care stay is three days (range 1 – 87), median in hospital stay is 23 days (range 7 – 87). Thirty-day mortality is 3.7 %. Median follow up is 42 months (range 0 – 127). One-, five- and ten-year overall actuarial survival is 87 %; 84 % and 51 % respectively. Median overall survival is 120 months. Patients with non-invasive IPMN have significantly better survival than patients with invasive IPMN and IPMN-associated carcinoma (p < 0.008). In the subgroup of invasive IPMN with associated carcinoma, a positive nodal state, perineural invasion as well as lymphovascular infiltration are associated with poor outcome (p < 0.0001; 37 U/l) as well as elevated lipase (>60 U/l) serum levels are associated with unfavorable outcome (p = 0.009 and 0.018; respectively). Patients operated for pancreatic ductal adenocarcinoma show significantly shorter long-term survival than patients with IPMN associated carcinoma (p = 0.001). Long-term outcome after pancreatic resection for non-invasive IPMN is excellent. Outcome after resection for invasive IPMN with invasive carcinoma is significantly better than for pancreatic ductal adenocarcinoma. In low- and intermediate risk IPMN with no clear indication for immediate surgical resection, a watchful waiting strategy should be evaluated carefully against surgical treatment individually for each patient.Keywords
This publication has 43 references indexed in Scilit:
- Intraductal Papillary-Mucinous Neoplasms of the Gastric and Intestinal Types May Have Less Malignant Potential Than the Pancreatobiliary TypePancreas, 2010
- Mucin-Producing Neoplasms of the Pancreas: An Analysis of Distinguishing Clinical and Epidemiologic CharacteristicsClinical Gastroenterology and Hepatology, 2010
- Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer PatientsClinical Cancer Research, 2009
- Current understanding of precursors to pancreatic cancerJournal of Hepato-Biliary-Pancreatic Surgery, 2007
- One Thousand Consecutive PancreaticoduodenectomiesAnnals of Surgery, 2006
- Invasive Carcinoma Originating in an Intraductal Papillary Mucinous Neoplasm of the PancreasPancreas, 2006
- Cystic Neoplasms of the PancreasNew England Journal of Medicine, 2004
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Intraductal Papillary Mucinous Neoplasms of the PancreasAnnals of Surgery, 2004
- Intraductal Papillary Mucinous Neoplasms of the PancreasAnnals of Surgery, 2004